6533b7dafe1ef96bd126e2ea
RESEARCH PRODUCT
Skin cancer screening – better safe than sorry
Janis SpigulisMarta LangeEmilija Vija PlorinaIlze LihacovaAleksandrs Derjabosubject
Seborrheic keratosismedicine.medical_specialtymultispectralnon-invasive01 natural sciences010309 opticslcsh:Social Sciences03 medical and health sciences0103 physical sciencesmedicinemelanomadiagnosticsBasal cell carcinomaStage (cooking)030304 developmental biology0303 health sciencesSkin cancer screeningintegumentary systemskin cancerbusiness.industryIncidence (epidemiology)MelanomascreeningCancerimagingmedicine.diseaseDermatologylcsh:HSkin cancerbusinessdescription
Skin cancer is the most common type of cancers. In Latvia, on average there are approximately 200 new melanoma and 1300 non-melanoma cancer cases per year. Non-melanoma cancers are: Basal Cell Carcinoma, Squamous Cell Carcinoma and others. It is essential to discover skin cancer at an early stage when it is treatable. For this reason, a reliable, non-invasive and quantitative skin cancer screening method is necessary in order to discover skin cancer as early as possible and to help physicians such as general practitioners and dermatologists assign patients to the best treatment as soon as possible. In this article, the current skin cancer incidence as well as the screening situation in Latvia is described and a non-invasive skin screening method is proposed. The results show that this multispectral imaging method with a parameter p′ can distinguish melanoma from melanocytic nevi with sensitivity 75% and specificity 100%. Recommendations on distinguishing henangioma, seborrheic keratosis are described as well.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-01-01 | SHS Web of Conferences |